Clarivate Plc Stock Price, News & Analysis

Clarivate Plc (NYSE: CLVT) has released a report highlighting the potential of telehealth to address healthcare disparities among Black Americans. The report emphasizes the need for equitable access to telehealth services, especially following the COVID-19 pandemic, which exposed significant gaps in healthcare accessibility. Challenges such as reimbursement structures and technology barriers hinder progress. Recommendations include enhancing reimbursement policies, investing in broadband infrastructure, and improving provider training in telehealth practices. The report aims to inform stakeholders on actionable strategies to improve healthcare equity.

Dana Incorporated (NYSE: DAN) has appointed Timothy R. Kraus as its new senior vice president and chief financial officer, succeeding Jonathan Collins, who will join Clarivate plc (NYSE: CLVT). Kraus, a Dana veteran with over a decade at the company, previously served as senior vice president of finance and treasurer, overseeing global treasury operations and strategic acquisitions. CEO James Kamsickas acknowledged Kraus's crucial role in Dana's transformation strategy, enhancing innovation and balance sheet strength. Collins will assist in the transition until December 15, 2021.

Clarivate (NYSE: CLVT) announced a leadership change with the departure of CFO Richard Hanks, effective December 16, 2021. His successor, Jonathan Collins, currently CFO of Dana (NYSE: DAN), will take over to drive the company's ongoing growth. Hanks will assist during the transition until April 1. Collins brings extensive experience from Dana and ProQuest, where he held senior financial roles. Clarivate's Executive Chairman praised Hanks for his contributions over the past five years and expressed confidence in Collins' ability to lead the financial strategy moving forward.

Clarivate has successfully completed its acquisition of ProQuest for $5.3 billion, enhancing its position as a global leader in information and analytics. This acquisition, announced on May 17, 2021, adds ProQuest's software, content, and analytics capabilities to Clarivate's portfolio. The combined entity now boasts over 11,000 employees serving 45,000 customers worldwide. The integration aims to unlock synergies and offer enriched services to research-focused organizations, while maintaining investment in existing product lines. Key leadership changes include Jonathan Collins as the new CFO.

Clarivate Plc (NYSE: CLVT) announced that its Executive Chairman Jerre Stead and CFO Richard Hanks will present at two upcoming virtual investor conferences. The presentations will take place at the BofA Securities Leveraged Finance Conference on November 30, 2021, at 8:15 am ET, and the Barclays Global Technology, Media, and Telecommunications Conference on December 7, 2021, at 3:35 pm ET. Webcasts for both events will be available for live access and replay. For more details, please visit Clarivate's website.

Clarivate Plc (NYSE:CLVT) has released its 2021 Highly Cited Researchers list, identifying 6,602 researchers globally, with 39.7% based in the United States, a decrease from previous years. Mainland China has seen significant growth, now boasting 935 researchers, nearly doubling its presence in four years. Key institutions include Harvard University with 214 researchers. This reflects a trend of globalization in research, with declines observed in the U.S. and U.K.

Clarivate Plc (NYSE: CLVT) announced that Executive Chairman Jerre Stead and CFO Richard Hanks will present at virtual investor conferences in November 2021. The first event is the RBC Capital Markets Global Technology Conference on November 17, 2021, at 9:35 AM ET, with a live webcast available for replay. The second event is the BofA Securities 2021 Leveraged Finance Conference on November 30, 2021, at 8:15 AM ET, also with a live webcast accessible for replay. For more details, visit clarivate.com.

Clarivate Plc (NYSE:CLVT) has been recognized by Forrester in their latest B2B2C Journey Mapping reports. These reports highlight the importance of transparency and trust in enhancing customer experiences. Clarivate's Customer Experience (CX) Services emphasizes the need for effective customer journey mapping, beginning with understanding customer feedback. The company also stresses the significance of recognizing partners' roles in customer experiences. This recognition underscores Clarivate's commitment to improving customer insights and driving business success.

Clarivate has partnered with the Biomedical Advanced Research and Development Authority (BARDA) to expedite the development of drug therapeutics that can serve as medical countermeasures (MCMs) for chlorine and sulfur mustard injuries. This collaboration will utilize machine learning and artificial intelligence to identify and repurpose existing FDA-approved drugs. Funding from BARDA will facilitate target identification and analyses, aiming to provide quicker responses to chemical exposure incidents. This initiative is part of BARDA's ReDIRECT program to enhance public health preparedness.